The Impact of GLP-1 Drugs on Migraine Management and Emergency Care Needs A recent study suggests a link between GLP-1 drugs and reduced emergency care for chronic migraine sufferers, shedding light on potential treatment benefits.

The Impact of GLP-1 Drugs on Migraine Management and Emergency Care Needs #United_States #Chicago #Chronic_Migraine #GLP-1_drugs #Topiramate

New Eptinezumab Trial Results Show Promise for Severe Migraine Treatment The phase IV RESOLUTION trial reveals that eptinezumab significantly reduces monthly migraine days in chronic migraine patients, paving a new treatment path.

New Eptinezumab Trial Results Show Promise for Severe Migraine Treatment #Denmark #Chronic_Migraine #Valby #Eptinezumab #RESOLUTION_Trial

New Phase III Trial Results Showcase Efficacy of Vyepti® for Chronic Migraine in Asian Patients The latest findings from the SUNRISE trial reveal significant improvements in chronic migraine treatment efficacy for the Asian population using Vyepti® (eptinezumab).

New Phase III Trial Results Showcase Efficacy of Vyepti® for Chronic Migraine in Asian Patients #Denmark #Chronic_Migraine #Valby #Vyepti #Eptinezumab

ShiraTronics Launches Pivotal Study for Neuromodulation Treatment to Alleviate Chronic Migraines ShiraTronics has begun pivotal study of its implantable neuromodulation therapy for chronic migraines in patients across the U.S. and Australia.

ShiraTronics Launches Pivotal Study for Neuromodulation Treatment to Alleviate Chronic Migraines #USA #Minneapolis #Chronic_Migraine #ShiraTronics #Neuromodulation